Single peptide Vial strength 10 mg
ARA-29010 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
ARA-290, explained simply
A peptide derived from a region of erythropoietin, studied in research on tissue and nerve protection.
Research area
Small nerve fibres and tissue protection
How it works
Designed to activate protective pathways linked to the innate repair receptor without reproducing erythropoietin's typical rise in red blood cells.
Why it matters
Research focuses particularly on small nerve fibres, neuropathic pain and inflammation.
What has been observed
Early clinical studies of neuropathic symptoms and small-fibre markers are cited alongside experimental tissue-protection data.
Effects and points to consider
Those observations involve specific studied populations and formulations, not every preparation labelled ARA-290.
01 / Vial strength 10 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg ARA-290 |
|---|---|
| Final volume | 2 mL |
| Concentration | 5 mg/mL |
| One U-100 unit | 50 mcg in 0.01 mL |
Human Study Calculation (2.0 mL = 5 mg/mL)
| Period | Amount per Administration | U-100 Units (mL) |
|---|---|---|
| Days 1–28 | 4 mg (4,000 mcg) | 80 units (0.80 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.